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Abstract
Findings from type 2 diabetes research indicate that sleep is both a predictor of onset and a
correlate of disease progression. However, the role sleep plays in glucose regulation and daytime
functioning in youth with type 1 diabetes mellitus (T1DM) has not been systematically
investigated. Nonetheless, preliminary findings have supported that various sleep parameters are
strongly correlated to health-related and neurobehavioral outcomes in youth with T1DM. This
suggests that improving sleep might reduce morbidity. A critical step in developing evidence-
based guidelines regarding sleep in diabetes management is to first determine that sleep
modification in natural settings is possible (i.e., instructing youth to have a healthy sleep
opportunity leads to more total sleep time) and that an increased sleep duration impacts disease
and psychosocial outcomes in these youth. This article describes the background, design, and
feasibility of an ongoing randomized clinical trial that aims to examine if increasing sleep relative
to youth’s own sleep routines affects glucose control and daytime functioning.
Type 1 diabetes mellitus (T1DM) affects approximately 1 in every 400 children and
adolescents (American Diabetes Association, 2011). T1DM is an autoimmune disease
whereby beta cells in the pancreas cease to produce of the insulin needed for natural
regulation of blood sugar (glucose). In the absence of naturally secreted insulin, blood sugar
levels are controlled by self-administration of exogenous insulin, adjustments for diet, and
engagement in physical activity (Johnson, Perwien, & Silverstein, 2000; Haugstvedt,
Wentzel-Larsen, Roken, & Graue, 2011). Well over 2/3 of youth with T1DM struggle to
achieve optimal glucose control, placing them at enormous risk for morbidity (e.g., organ
damage, blindness) and premature death (ADA, 2011; Johnson et al., 2000; Haugstvedt et
al., 2011). Thus, a pressing need exists to develop innovative and sustainable approaches to
improve glucose regulation in youth with T1DM.
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Diabetes and Sleep Insufficiency
Current recommendations for sleep duration are that school-age youth through age 13
should obtain 9–11 hours per night and older adolescents (14+ years) should obtain 8–10
hours of sleep per night for optimal health and wellbeing (Hirshkowitz et al., 2015). Tarokh,
Carskadon, and Achermann (2012) demonstrated that adolescents have a biological need for
at least nine hours of sleep per night. However, nearly 2/3 of youth fail to obtain the
recommended sleep duration (Perfect, Levine-Donnerstein, Archbold, Goodwin, & Quan,
2014). Higher rates of sleep disturbances in youth with T1DM may be evident as early as the
preschool years (Monaghan, Herbert, Cogen, & Streisand, 2012) and continue into
adolescence (Caruso et al., 2014). With regard to sleep duration, studies have supported that
high rates of inadequate total sleep time (TST) exist amongst youth with T1DM (Estrada,
Danielson, Drum, & Lipton, 2012; Jaser & Ellis, 2016; Perfect, 2014). Although Monaghan
found that the average TST (11.69 hours inclusive of naps) for 24 preschoolers with T1DM
fell within the recommended range (10 to 13 hours), considerable variability existed and
most children did not achieve the upper limit. Very few studies have reported objectively
measured sleep duration in school-age youth with T1DM relative to those without diabetes;
studies using polysomnography (PSG) revealed that youth with T1DM had shorter sleep
duration than healthy peers/controls (Matyka, Crawford, Wiggs, Dunger, & Stores, 2000;
Perfect et al., 2012; Pillar et al., 2003). Using actigraphy, we have previously reported that
the average weekly sleep duration was less than seven hours for a sample of 10 to 16 year
olds with T1DM (Perfect et al., 2012).
Despite some evidence of insufficient sleep, it is unclear whether sleep has a direct impact
on glycemic control. One study (Jaser & Ellis, 2016) did not yield a significant correlation
between TST and glucose control, but sleep quality and HbA1c were related among male
adolescents. Our previous cross-sectional study supported that shorter sleep duration related
to higher HbA1c levels in 10 to 16 year olds (Perfect, 2014). The mechanisms may be due to
sympathetic activation, increased stress hormones (cortisol), or increased inflammation.
Beyond the physiological underpinnings of shortened sleep, sleep insufficiency may impact
adherence in diabetes management. Effective management of diabetes requires day-to-day
decision making, emotional and behavioral regulation, attention, planning, comprehension,
and memory (McNally, Rohan, Pendley, Delamater, & Drotar, 2010). Data from healthy
populations have indicated that insufficient sleep has been associated with impairment in
these skills (Dewald, Meijer, Oort, Kerkohof, & Bögels, 2010; Perfect et al., 2014; Steenari
et al., 2003). In this regard, Jaser and Ellis (2016) did find a significant association between
sleep duration and blood glucose checks.
Experimental Manipulation of Sleep
Despite the plausibility of sleep’s role in glucose regulation and skills that foster adherence
to treatment, the American Diabetes Association’s (ADA, 2016) current standards of care in
the management of T1DM are devoid of recommendations for sleep, most likely because of
the lack of evidence demonstrating a causal relationship between better sleep and improved
outcomes for youth with T1DM. In contrast, the potential impact of insufficient sleep on
glucose and insulin sensitivity (body’s response to insulin; Matsuda & DeFronzo, 1999) has
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been demonstrated within adult experimental protocols employing a moderate sleep
restriction condition (generally 4 to 5 hours ranging from one night to multiple weeks;
Buxton et al., 2010; Buxton et al., 2012; Reynolds et al., 2012; Spiegel, Leproult, & Cauter,
1999; van Leeuwen et al., 2010) and adults with T1DM (Donga et al., 2010). Furthermore,
clinical trials with adult samples have demonstrated that extending sleep over six weeks to
twelve months in natural environments is feasible (Cizza et al., 2011; Leproult, Deliens,
Gilson, & Peigneux, 2015). Further, in non-obese adults, the additional sleep contributed to
improved insulin sensitivity and glucose levels (Leproult et al., 2015) as well as
neurocognition (Lucassen et al., 2014).
No such experimental sleep manipulation studies have been published on youth with T1DM.
However, healthy youth and youth with asthma can follow a home-based sleep modification
protocol, including sleep extension instructions (Beebe et al., 2008; Beebe, Rose, & Amin,
2010; Beebe et al., 2013; Fallone, Acebo, Seifer, & Carskadon, 2002; 2005; Gruber,
Cassoff, Frenette, Wiebe, & Carrier, 2012; Meltzer et al., 2015; Sadeh, Gruber, & Raviv,
2003; Jiang et al., 2011). These studies found that within a short timeframe, decreases in
sleep duration demonstrated negative effects on cognition, behavior, and diet (Beebe, et al.,
2010; Beebe et al., 2013; Fallone et al., 2005; Gruber et al., 2012; Jiang et al., 2011; Sadeh
et al., 2003). Such sleep restriction studies have merit in that they establish that changing
sleep duration results in adverse physiological or psychological outcomes. However,
because youth with T1DM are frequently sleep deficient, a more clinically important
question is whether increasing sleep duration produces measureable positive outcomes. In
this regard, new studies have highlighted potential benefits of youth obtaining additional
sleep (i.e., recommending a specific ‘healthy sleep opportunity,’ or time in bed, in
anticipation that a participant will increase TST), including improvements with attention,
memory, problem-solving, emotional regulation, and depression (Dewald-Kaufman, Oort, &
Meijer, 2013; 2014; Gruber et al., 2012; Sadeh et al., 2003).
Study Aims
Although there is a relative lack of knowledge pertaining to the association between T1DM
and sleep, a number of studies have suggested that an adverse relationship exists. There is
evidence of a causal link between inadequate sleep and endocrine functioning in adults with
and without diabetes and neurobehavior in non-medically involved youth, but due to
maturational changes that occur during adolescence, the burden of a complex medical
regimen, and the physiological underpinnings of T1DM, successful execution and benefit in
this pediatric population remains to be determined. Thus, to truly determine the causal
contribution of sleep in the health and functioning of youth with T1DM, it is necessary to
perform a randomized control trial (RCT) to demonstrate that a sleep intervention results in
a change in a T1DM outcome. The ultimate goal of this line of research is to demonstrate
improvements in Hemoglobin A1c (HbA1c), which is the “gold standard” measurement of
glucose control and a metric of average glucose over approximately a three month period
(ADA, 2016). This would necessitate a sleep intervention that is unprecedented in pediatric
diabetes research. Given the costs and complexity of multi-site, large scale-RCTs,
particularly ones that are of longer duration, we undertook a RCT to examine a brief
pediatric sleep extension intervention to establish a well-developed set of procedures,
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ascertain perceptions of youth with T1DM and their families regarding the intervention, and
obtain preliminary evidence of effect (i.e., short-term efficacy). This paper describes the
design and feasibility of data collected in the context of this RCT. We address
considerations including (1) the sufficiency in the number of youth who evidenced
inadequate sleep duration and were willing to participate; (2) the development of the study
procedures and adherence to our sleep modification consultation instructions; and (3)
feedback reported by study participants.
Method
Participants
This study reports data from 79 participants who were enrolled as part of a larger, ongoing
RCT examining the efficacy of a brief sleep extension intervention on glucose control and
neurobehavioral functioning in youth with T1DM. Participants, between the ages of 10–16
with a confirmed diagnosis of T1DM as defined by the ADA, were recruited exclusively
from one pediatric endocrinology clinic in the Southwest region of the United States. To be
included, child participants were required to speak, read, and understand English, and have
at least one caregiver willing to participate. Exclusion criteria included (1) psychiatric,
cognitive, genetic (e.g., Down syndrome, Prader-Willi syndrome, Fragile X), or neurological
conditions (e.g., epilepsy) that could significantly impact sleep, neurobehavioral
performance, glucose control, or participation; and (2) hospitalization within one month of
enrollment. Based on recommended sleep durations, participants were eligible for
randomization if they slept <9.5 hours for 10 to 13 year olds and <9 hours for 14+ year olds
(Hirshkowitz et al., 2015; Tarokh et al., 2012).
Measures
To show the depth of the overall protocol in the context of all study procedures, including a
comprehensive neurobehavioral evaluation, we provide a Supplemental online table that
includes the measures we administered, including the respondent perspective, and
descriptions of the information yielded from them. Continuous glucose monitors (CGMs)
were used to assess glucose levels and variability as these devices are recognized for
capturing short-term, day-to-day fluctuations in glycemic control. We used the iPro-CGM
(Medtronics, Minneapolis, MN), which is an FDA-approved blinded device, validated for
use with children under 18 to track glucose levels every 5 minutes (Agus, Alexander,
Wolfsdorf, 2010; Al-Ansary et al., 2011; Alleyn et al., 2011). Retrospective CGM
recordings have the benefit of not influencing diabetes management during clinical trials
(Muchmore, Sharp, & Vaughn, 2011). It is placed subcutaneously with the recorder attached
to the sensor. Youth were instructed to continue with their diabetes regimen, but for CGM
calibration purposes, asked to obtain finger-stick blood glucose levels at least four times a
day with the provided meter and strips. Using the glucose logs, participants were asked to
record their carbohydrate intake, exercise intensity, insulin adjustments, and meter readings.
The self-reported meter values were used as a backup in case of meter failure or in instances
when an alternative meter had been used for which values were not available. During one
night of the Naturalistic Sleep Period, each child underwent a home-based PSG. The PSG
was recorded using the Compumedics Somté system (Abbotsford, Victoria, Australia). PSG
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allows for ascertainment of sleep stages (N1, N2, N3, REM) via electroencephalogram
(EEG), sleep-disordered breathing via respiratory channels, sleep quality, and sleep duration
(Iber, Acoli-Israel, Chesson, & Quan, 2007). Concurrent with the CGM, participants wore
an actigraph (Actiwatch-Spectrum, Philips Respironics), which is a wristwatch-sized device
that records the frequency of movement to estimate sleep-wake patterns in 30 second
intervals. Actigraphy data have been found to correlate with PSG data (Iber, Ancoli-Israel,
Chesson, & Quan, 2007; Ancoli-Israel et al., 2003; Meltzer, Montgomery-Downs, Isana, &
Walsh, 2012), be valid for use with children and adolescents (Ancoli-Israel et al., 2003;
Meltzer, et al., 2012), and allow for continuous serial data collection over several days.
At the final study visit (Neurobehavioral Evaluation #2), participants and caregivers were
asked to complete an exit survey and provide the study team with feedback about their
experience. Questions inquired about the ease of the child extending his/her sleep (sleep
extension condition only), how successful the child was perceived to be at extending or
maintaining his/her sleep, how helpful the sleep consultation was in modifying the child’s
sleep, and how likely the child was to continue the assigned sleep schedule after the study
ended.
Procedure
The study was approved by the local human subject protection program. Prior to initiating
the RCT, we ran nine participants through all the anticipated procedures to solidify the sleep
extension intervention components, determine potential barriers to implementation, and
select viable study endpoints. To collect data using a multi-setting, multi-informant, and
multi-method approach, the study typically involved three clinic visits, one home visit, and
two school visits during the 12-day participation. These occurred in the following order: (1)
consent; (2) home-based sleep study; (3) school visit #1; (4) end of Naturalistic Sleep
period/Neurobehavioral Evaluation #1/start of Sleep Modification period; (5) school visit
#2; and (6) end of Sleep Modification period/Neurobehavioral Evaluation #2. Participants’
baseline, referred to as the Naturalistic Sleep period, involved tracking sleep and glucose for
approximately six days as well as a battery of neurobehavioral measures. For the Sleep
Modification period, also lasting approximately six days, participants were randomly
assigned to one of two conditions: Sleep Extension or Fixed Sleep Duration.
Recruitment—Our primary method of recruitment occurred at potential participants’
regularly scheduled clinic visits in which they were given information about the study.
Participants were initially asked by clinic staff if they would grant permission for a research
team member to describe the study. Patients were given the option to decline, schedule,
provide information for follow-up, or participate immediately if an opening existed. If a
research team member was not available, clinic staff asked the potential participant to leave
contact information. As this study was occurring over multiple years and to preserve
privacy, no identifying information was retained for patients who did not provide contact
information. Clinic staff or research team members recorded basic demographic information
and patient-provide reason for refusal for families who opted not to meet with a researcher,
give contact information, or enroll after hearing about the study.
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Initial intake (consent visit)—Enrollment began with a consent visit during which
participants provided written assent, had an actigraph placed on their non-dominant wrist,
and had a CGM inserted. Guardians signed a consent document and a release of information
for school data. They were also provided meters and strips (50), a glucose log, and a sleep
diary.
Naturalistic Sleep period (baseline)—We instructed participants to follow their typical
school week and weekend sleep schedules, but to wake up at the time they would for school
if they were absent. At the end of the Naturalistic Sleep period, participants returned their
devices, completed forms, and underwent Neurobehavioral Evaluation #1. This evaluation
lasted approximately 3.5 hours during which a parent spent about 30 to 45 minutes
completing questionnaires. The evaluator, trained on neurobehavioral assessments as part of
a doctoral program of study, was blinded to the Sleep Modification condition until after the
evaluation was completed. We strived to balance team members in the number of
Naturalistic and Sleep Modification evaluations they completed; no team member completed
both evaluations for any participant.
Sleep Modification period (intervention)—After completing the neurobehavioral
measures, a research team member computed average Naturalistic sleep duration using data
from the sleep diary and actigraphy. As with other sleep modification studies (Beebe et al.,
2008; Fallone et al., 2002; Gruber et al., 2012; Leproult, Deliens, Gilson, & Peigneux, 2015;
Lucassen et al., 2014) that have incorporated both methods of assessing sleep duration, we
established a protocol to use a combination of the two to mitigate inaccuracies in actigraphy
due to variability in children’s motoric activity and the unknown credibility of the sleep
diary (Short, Gradisar, Lack, Wright, & Carskadon, 2012). We also focused on time in bed
increases (considering the light data from actigraphy to determine whether an adolescent
attempted to follow the instructions (i.e., modify their sleep/comply with sleep schedule). In
the small number of cases for which the diary and actigraphy were widely discrepant, the
research team member conferred with another team member and/or PI to determine if the
actigraphy data should be used for TST (Ashworth et al., 2015).
The team member then provided a newly initialized actigraph and CGM, as well as a new
sleep diary, glucose log, and more glucose strips. At that time, the evaluator learned the
assignment of the participants’ Sleep Modification condition (e.g., Sleep Extension or Fixed
Sleep Duration) and revealed to the participant and caregiver. To increase power, efficiency,
and reduce bias, random assignment included stratification based on Tanner Stage Groups
[pre-pubertal (Stage I), early puberty (Stages II–III), and late puberty (Stage IV–V; Kernan,
Viscoli, Makuch, Brass, Horwitz, 1999; Kahan & Morris, 2012)]. The groupings are
consistent with research on insulin resistance and pubertal circadian rhythm changes (Moran
et al., 1999).
The consultation intervention, which lasted approximately 20 minutes, was delivered by the
same individual who completed the evaluation. For both conditions, interventionists
reviewed actigraphy and diary data with the student in the presence of at least one caregiver.
The review included patterns, bedtimes and wake-times plus sleep onset and offset, sleep
disruptions (e.g., longer latency and frequent/long awakenings), and light exposure (e.g.,
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blue light suggesting technology usage). At the end of the Sleep Modification week, the
interventionist met with families to review data. Once again, if the veracity of the diary was
in question, the interventionists used discretion and/or consulted with the supervising PI to
determine what information should be conveyed to families about their child’s estimated
TST change from one week to the next.
Sleep extension—To improve the likelihood of obtaining a healthy sleep opportunity, the
research team member and family worked collaboratively to address factors that interfere
with sleep onset and quality sleep. Table 1 provides the general target areas of the
consultation for the Sleep Extension participants, which involved instructing participants to
increase their time in bed to up to 10 hours or one hour more than their Naturalistic Sleep,
whichever was greater (Beebe et al., 2008; Fallone, et al., 2002). At the consultation, the
trained research team member asked participants about their daily routines (particularly
afterschool/evening) and focused on behaviors/conditions that were relevant for the child.
This consultation was based on procedures used in previous sleep modification studies with
children and adolescents (Beebe et al., 2008; Beebe et al., 2013: Fallone et al., 2002; Jiang et
al., 2011; Sadeh et al., 2003) and research demonstrating factors that contribute to sleep
disturbances and sleep habits that interfere with daytime functioning, (Dworak, Schierl,
Bruns, & Strüder, 2007; Jones, Owens, & Pham, 2013; Paterson, Nutt, Ivarsson, Hutson, &
Wilson, 2009; Perfect et al., 2012). This “prescription” was individualized, reviewed by the
adolescent/family, and considered barriers to implementation.
Fixed sleep duration condition—In contrast with other sleep modification studies in
natural settings, we did not want to include a ‘sleep restriction condition’ as research has
shown that less sleep is harmful and would be problematic while participants are attending
school. Therefore, as most youth were already getting insufficient sleep, we prescribed a
duration anchored to their average baseline TST (Naturalistic) to reduce the chances of them
getting more sleep during the Sleep Modification period. To balance time with research
team members, the consultation was neutral and focused on obstacles to being compliant
with the prescribed number of hours.
Mid-week check-in—A mid-week check was conducted in both sleep modification
conditions during the six day intervention period. The interventionist (i.e., graduate research
assistant who delivered the intervention) called the family to inquire about compliance with
the instructions and to determine if any difficulties with the prescribed sleep schedule
occurred. If needed to increase adherence to the sleep schedule, the interventionist worked
with the family over the phone to troubleshoot problems, reminding them of the strategies
discussed in the consultation.
Results
Recruitment and enrollment data
Three-hundred and eighty-eight recruitment attempts (i.e., clinic staff asked the patient
permission for a research team member to approach or to provide contact information when
a team member was not available) resulted in 180 participants providing contact
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information, of whom 79 enrolled. These patient inquiries were not necessarily unique
cases; some patients may have been informed of the study multiple times. Recruitment for
the year stopped due to summer break; thus, there were many potentially eligible
participants who could not be scheduled prior to the end of the school year. Additionally,
6.74% of patients who had a scheduled consent visit cancelled or no showed. Among the 79
participants, 34 (44.74%) participants identified as Latino/Latina. Nearly half (48.68%) are
females. HbA1c ranged from 5.4% [6 mmol/L) to 12.90% (17.9 mmol/L; mean=9.04%
(11.8 mmol/L), SD= 1.91% (.4 mmol/L)]. Sixty participants (76.92%) out of 78 with
available HbA1c had values above 7.5%. The mean age of participants was 13.14 years.
These characteristics mirror the clinic patient population.
Sleep sufficiency
The overall mean sleep duration of the sample at baseline, as recorded by actigraphy and
diary, was 7.46 (SD = .73) and 8.21 (SD = .91) hours, respectively. Although the difference
in objectively-measured and self-reported sleep duration constituted a 40 minute difference,
the mean actigraphy sleep period (onset to offset) was 8.05 hours (SD = 1.24 hours), which
more closely mirrored the diary data. Based on the averaged TST between actigraphy and
diary above our TST cutoff, three participants were not randomized (3.80%).
Completion data
None of the 79 participants withdrew from the study. More than 90% of participants were
able to use all the equipment following exact study procedures and without any equipment
malfunctions for both Naturalistic and Sleep Modification periods. Four participants (5.1%)
had missing CGM data during the Naturalistic Sleep period as a result of: replacing the
study device with their own CGM device; CGM falling out and participant refusing
reinsertion; and not performing enough finger-sticks to calibrate the CGM. During the Sleep
Modification period, CGM data were missing for five participants (6.3%) for the following
reasons: continuing to use their own CGM (same participant from baseline), continued
without reinsertion (same participant from baseline), not enough finger-sticks to calibrate
CGM (same participant from baseline), and problems retrieving the data from the CGM.
Two participants (2.5%) had missing or insufficient (<3 days) Naturalistic Sleep actigraphy
data due to taking off the watch for an extended period of time. In the Sleep Modification
period, one participant (1.3%) again, removed the watch resulting in insufficient actigraphy
data. We redid two out of four PSGs (prior to the intervention) due to insufficient data.
Sleep modification compliance
Nearly 80% of participants assigned to the Sleep Extension condition obtained at least 15
minutes additional sleep each intervention night than during their Naturalistic Sleep period,
with 1/3 of them increasing their sleep duration by over an hour. The average increase in
TST was 40.95 (SD = 47.93) minutes; actigraphy showed 28.61 (SD = 37.61) minutes
increased from baseline, and diary showed 47.75 (SD = 75.31) minutes increased. In
contrast, participants assigned to the Fixed Sleep Duration condition had negligible overall
change in sleep duration (3.69 minutes increase for actigraphy and 10.38 increase in diary),
with an average of 6.39 minute difference between TST during the Naturalistic and Sleep
Modification periods. Collectively, youth in the Sleep Extension condition slept
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significantly longer than their own baseline and significantly more minutes than youth in the
Fixed Sleep Duration condition. Even so, one in five youth in the Sleep Extension condition
failed to increase their sleep by at least 15 minutes, whereas one in four in the Fixed Sleep
Duration condition ended up increasing their sleep by at least that long (See Table 2).
Participant feedback
Table 3 provides comments regarding facilitators and barriers to modifying sleep schedules.
For youth participants randomized to the Sleep Extension condition and their parents, 60–
66% reported that it was somewhat to very difficult to extend their sleep, respectively. When
asked how likely participants were to continue with the sleep schedule used for the study,
55% of youth in the control condition said they were very likely to somewhat likely to
continue, 22.5% were somewhat to very unlikely to continue, and 15% were unsure if they
would continue. The sleep extension group was less likely to endorse a desire to continue
their prescribed sleep schedule as 45.5% reported being very likely to somewhat likely;
23.8% being somewhat to very unlikely, and 17.9% were unsure if they would continue.
Caregivers also answered a question asking how helpful they perceived the sleep
consultation to in successfully modifying their child’s sleep. Overall, most of the caregivers
in the Sleep Extension group felt the sleep consultation was somewhat or very helpful
(25.6% and 51.3%, respectively). The control group did not differ greatly in their viewing of
the sleep consultation as helpful.
Discussion
Given that 60% to 80% of youth with T1DM experience suboptimal control (Moore,
Hackworth, Hamilton, Northam, & Cameron, 2013), a critical need exists to improve
standard clinical care and interventions in this population. The current study demonstrates
that it is possible to implement a sleep extension intervention in a cohort of youth with
T1DM who participate in a RCT. Our primary objective of the overarching study was to
determine the role that sleep had in health and psychosocial outcomes in youth with T1DM.
We propose that sleep should be an integral part of diabetes management; and therefore,
studies are needed to demonstrate that increasing sleep duration produces measureable,
positive outcomes reversing the effects of prior self-imposed sleep restriction.
The data presented in this article pertained to the feasibility of implementing a sleep
extension intervention in youth with T1DM, a population known to have difficulty with
adherence to health behaviors. Overall, similar to prior sleep extension studies in natural
environments, 80% of youth with T1DM followed the sleep extension instructions for one
week. They did so despite the fact that the majority reported that the prescribed sleep
schedule was ‘somewhat’ or ‘very’ difficult. One caution is that only 45.5% indicated they
would be at least somewhat likely to continue the sleep schedule. It is possible that it could
become easier as youth acclimate to the earlier bedtimes over time. Nonetheless, researchers
employing interventions with the intention to impact glycemic control and daytime
functioning should determine exactly what strategies are needed to ensure sustainability.
The data show that youth are willing to monitor and extend their sleep, at least in the short
term. If youth increased sleep by as little as 15 minutes per night, they would obtain 7.5
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hours additional sleep per month, and 90 more hours of sleep in a year. The benefit of
different “doses” of additional sleep has not been tested. However, put in perspective,
certain pharmacological treatments deemed to be clinically efficacious to target sleep
problems produce a ~15 minute increase in TST (Cizza, Piaggi, Rother, & Csako, 2014;
Roth, Hull, Lankford, Rosenberg, & Scharf, 2008).
Design Considerations, Future Interventions, and Consideration of Sustainability
The study components were developed based on previously published studies (Beebe et al.,
2008; Fallone et al., 2002; Gruber et al., 2012; Meltzer et al., 2015; Sadeh et al., 2003). One
distinction for some of those studies is that their primary aim was to experimentally
manipulate sleep (both restricted and extended) to show contrasting effects of sleep on
outcomes of interest. However, very few studies aimed to use sleep as an intervention that is
meant to be long lasting.
Data from the Fixed Sleep Duration (control) group suggest that instructions to maintain
consistent sleep duration may effectively prevent inadvertent additional sleep during a sleep
modification study, though some may experience less sleep and others may exhibit an
increase. As responses to our exit surveys indicated, one possible explanation for this
finding is that these families were expecting to find out how their adolescents could get
more sleep (even though we did not state this as the purpose). The impact of participants’
expectations entering a sleep extension study was illustrated in another recent trial in which
adults with obesity experienced improvements in overall health even prior to randomization
(Cizza, Piaggi, Rother, & Csako, 2014). One solution may be to not prime participants that
the sole focus of the study is related to sleep or to do a full cross-over design in which all
participants experience both experimental conditions. Further, obtaining more consistent
sleep, albeit still below recommendations for the age group, may have some benefit. Thus, a
control group in a study of longer duration (i.e., 3 months to mirror quarterly visits typical of
youth with T1DM) may be further differentiated if youth were allowed to maintain their
natural sleep patterns.
As we refine the sleep modification condition and move toward sustainability, we are
considering the tools that might help participants change their lifestyle to allow for more
sleep opportunity and quality, such as training or referrals to engage in basic mind-body
techniques (e.g., self-hypnosis, mindfulness, yoga; Perfect & Smith, 2016) that have been
shown to be helpful in reducing stress and/or insomnia. Further, we may need to employ
motivational interviewing techniques to work with participants to adopt healthier sleep
habits (Cassoff, Rushani, Gruber, & Knauper, 2014). In addition, an alternative approach to
sleep extension, as employed by other investigators, (Dewald et al., 2013; 2014), would be
to instruct adolescents to increase their sleep in 5-minute increments rather than increased
time in bed all at once. This may be necessary for “treatment-resistant” youth who need to
gradually adjust their circadian rhythm. However, many youth show day-to-day fluctuations
in sleep that far exceed five minutes, suggesting that less cautious adjustments produce
change. We found the bigger challenge was modifying routines to enable youth to spend
more time in bed rather than with how long it took them to fall asleep.
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Another consideration is the method of measuring sleep duration. The PSG data provide an
objective metric of sleep duration but does not capture night-to-night variability in TST
(Perfect et al., 2012). The actigraphy is a validated measure in children, but has previously
been reported to potentially underestimate adolescent sleep (Short et al., 2012). However,
sleep diary relies on the adolescent both being compliant with completing it as well as being
accurate in the information provided. Some adolescents may also overestimate as well. In
this regard, the rest interval (i.e., time in bed) may more closely align with the self-reported
sleep times. Thus, our determination of sleep duration at each time point and the difference
between the two may be less precise than polysomnography. Consequently, for studies that
examine sleep duration change as the outcome or as a mediating or moderating effect on an
outcome (e.g., glucose), use off multiple methods of time in bed, sleep duration, and self-
reported data should be considered.
Conclusions
At the present time, scarce information exists about sleep and its potential impact on
diabetes disease progression or morbidities in youth with T1DM. Yet, youth should spend a
significant portion of their day sleeping. Our long-term goal is to determine the role that
sleep has in health and neurobehavioral outcomes of youth with T1DM. It is anticipated that
the data from the parent RCT will establish the short-term efficacy of providing a healthy
sleep opportunity in youth with T1DM, laying the groundwork for future studies examining
longer-term sustainability and impact. The strength in our sleep modification consultation
approach is that it is relatively brief (~20 minutes for the initial discussion), straightforward,
acceptable to most families, and could be integrated into diabetes education. Thus, this study
lays the foundation for a large scale RCT to empirically examine if consistently achieving or
obtaining close to recommended amounts of sleep leads to clinical improvements in youth
with T1DM.
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Table 1
Sleep Intervention Components
1. Knowledge Review the importance of getting more sleep and potential impact
of not sleeping enough
Consider sleepiness levels and sleep pressure
2. Nightly Routine Develop routine consistent with bedtime
Begin preparing for bed with enough time to be attempting sleep at
set bedtime (nighttime diabetes management)
3. Competing Activities Discuss competing activities (e.g., homework,
dinner time, sports)
Adjust timing of activities to accommodate bedtime
4. Environmental Conditions Limit light in the room at night (e.g., curtain for morning light,
turning light off at bedtime)
Sibling or pets in the room at night that may be distractions
5. Lifestyle Limiting moderate to high intensity exercise 2 hours before
bedtime
No caffeine intake after dinner or 2-3 hours before bedtime
6. Technology No technology (e.g., TV, video games, etc.) 1-2 hours before
bedtime
No cell phone in the room at bedtime
7. Stress Reduce overload of information by breaking down expectations
related to sleep schedule
Address basic strategies to manage stress
8. Parental Monitoring Meet with child and parent to establish sleep schedule for week
Empower parents with monitoring child’s sleep
behaviors/schedule
Note: Interventionists inquire about each of these areas, but develop a “prescription” of behaviors that includes recommendations mutually agreed
upon between the family and interventionist. The session concludes with a discussion of strategies and barriers to implementation.
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